{"id":"https://openalex.org/W7224128671","doi":"https://doi.org/10.1111/cup.70224","title":"NTRK1 \u2010Rearranged Cutaneous Non\u2010Langerhans Cell Histiocytosis With Durable Response to TRK Inhibitor in a Patient With Primary Myelofibrosis","display_name":"NTRK1 \u2010Rearranged Cutaneous Non\u2010Langerhans Cell Histiocytosis With Durable Response to TRK Inhibitor in a Patient With Primary Myelofibrosis","publication_year":2026,"publication_date":"2026-10-28","ids":{"openalex":"https://openalex.org/W7224128671","doi":"https://doi.org/10.1111/cup.70224","pmid":"https://pubmed.ncbi.nlm.nih.gov/42949567"},"language":"en","primary_location":{"id":"doi:10.1111/cup.70224","doi":"https://doi.org/10.1111/cup.70224","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cup.70224","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cup.70224","source":{"id":"https://openalex.org/S92442678","display_name":"Journal of Cutaneous Pathology","issn_l":"0303-6987","issn":["0303-6987","1600-0560"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cutaneous Pathology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cup.70224","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039077180","display_name":"Scott Kuan-Wen Wang","orcid":"https://orcid.org/0009-0008-9211-887X","observed_orcids":["https://orcid.org/0009-0008-9211-887X"]},"institutions":[{"id":"https://openalex.org/I1302163369","display_name":"Hartford Hospital","ror":"https://ror.org/00gt5xe03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302163369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Scott Kuan\u2010Wen Wang","raw_affiliation_strings":["Department of Pathology and Laboratory Medicine Hartford Hospital  Hartford Connecticut USA"],"raw_orcid":"https://orcid.org/0009-0008-9211-887X","affiliations":[{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine Hartford Hospital  Hartford Connecticut USA","institution_ids":["https://openalex.org/I1302163369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130221644","display_name":"Dean George","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1302163369","display_name":"Hartford Hospital","ror":"https://ror.org/00gt5xe03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302163369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dean George","raw_affiliation_strings":["Hartford Healthcare Cancer Institute, Hartford Hospital  Hartford Connecticut USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hartford Healthcare Cancer Institute, Hartford Hospital  Hartford Connecticut USA","institution_ids":["https://openalex.org/I1302163369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028626514","display_name":"Nan Guo Ring","orcid":"https://orcid.org/0000-0001-7343-4908","observed_orcids":["https://orcid.org/0000-0001-7343-4908"]},"institutions":[{"id":"https://openalex.org/I1302163369","display_name":"Hartford Hospital","ror":"https://ror.org/00gt5xe03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302163369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nan Ring","raw_affiliation_strings":["Department of Pathology and Laboratory Medicine Hartford Hospital  Hartford Connecticut USA"],"raw_orcid":"https://orcid.org/0000-0001-7343-4908","affiliations":[{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine Hartford Hospital  Hartford Connecticut USA","institution_ids":["https://openalex.org/I1302163369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075670976","display_name":"Nicholas Dainiak","orcid":"https://orcid.org/0000-0002-8498-0987","observed_orcids":["https://orcid.org/0000-0002-8498-0987"]},"institutions":[{"id":"https://openalex.org/I1302163369","display_name":"Hartford Hospital","ror":"https://ror.org/00gt5xe03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302163369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Dainiak","raw_affiliation_strings":["Hartford Healthcare Cancer Institute, Hartford Hospital  Hartford Connecticut USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hartford Healthcare Cancer Institute, Hartford Hospital  Hartford Connecticut USA","institution_ids":["https://openalex.org/I1302163369"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024336923","display_name":"Leslie Robinson\u2010Bostom","orcid":"https://orcid.org/0000-0001-6551-7762","observed_orcids":["https://orcid.org/0000-0001-6551-7762"]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Robinson\u2010Bostom","raw_affiliation_strings":["Department of Dermatology The Warren Alpert Medical School of Brown University  Providence Rhode Island USA","Department of Pathology and Laboratory Medicine The Warren Alpert Medical School of Brown University  Providence Rhode Island USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology The Warren Alpert Medical School of Brown University  Providence Rhode Island USA","institution_ids":["https://openalex.org/I27804330"]},{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine The Warren Alpert Medical School of Brown University  Providence Rhode Island USA","institution_ids":["https://openalex.org/I27804330"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5039077180"],"corresponding_institution_ids":["https://openalex.org/I1302163369"],"apc_list":{"value":3570,"currency":"USD","value_usd":3570},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.84033333,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11909","display_name":"Histiocytic Disorders and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11909","display_name":"Histiocytic Disorders and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ntrk1-rearrangement","display_name":"NTRK1 rearrangement","score":0.9480000138282776},{"id":"https://openalex.org/keywords/non-langerhans-cell-histiocytosis","display_name":"non-Langerhans cell histiocytosis","score":0.9449999928474426},{"id":"https://openalex.org/keywords/cutaneous-histiocytosis","display_name":"cutaneous histiocytosis","score":0.8560000061988831},{"id":"https://openalex.org/keywords/primary-myelofibrosis","display_name":"primary myelofibrosis","score":0.9190000295639038},{"id":"https://openalex.org/keywords/larotrectinib","display_name":"larotrectinib","score":0.9710000157356262},{"id":"https://openalex.org/keywords/trk-inhibitors","display_name":"TRK inhibitors","score":0.8379999995231628},{"id":"https://openalex.org/keywords/ruxolitinib-resistance","display_name":"ruxolitinib resistance","score":0.8679999709129333},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.699999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8723000288009644},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.8029999732971191},{"id":"https://openalex.org/C43100952","wikidata":"https://www.wikidata.org/wiki/Q654612","display_name":"Histiocyte","level":2,"score":0.7034000158309937},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.6996999979019165},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.6212999820709229},{"id":"https://openalex.org/C134139212","wikidata":"https://www.wikidata.org/wiki/Q24719927","display_name":"Trk receptor","level":4,"score":0.5995000004768372},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.5358999967575073},{"id":"https://openalex.org/C2780174970","wikidata":"https://www.wikidata.org/wiki/Q1411740","display_name":"Histiocytosis","level":3,"score":0.5356000065803528},{"id":"https://openalex.org/C2777578932","wikidata":"https://www.wikidata.org/wiki/Q5773034","display_name":"Histiocytic sarcoma","level":3,"score":0.4571000039577484},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4269999861717224},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.4065999984741211},{"id":"https://openalex.org/C2779945361","wikidata":"https://www.wikidata.org/wiki/Q1349259","display_name":"Erdheim\u2013Chester disease","level":4,"score":0.40639999508857727},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.3781999945640564},{"id":"https://openalex.org/C156662089","wikidata":"https://www.wikidata.org/wiki/Q6931223","display_name":"Mucocutaneous zone","level":3,"score":0.37369999289512634},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3734999895095825},{"id":"https://openalex.org/C2910274570","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative Disorders","level":2,"score":0.36730000376701355},{"id":"https://openalex.org/C2777484599","wikidata":"https://www.wikidata.org/wiki/Q374036","display_name":"Langerhans cell histiocytosis","level":3,"score":0.3555000126361847},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.3321000039577484},{"id":"https://openalex.org/C2781107747","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative neoplasm","level":4,"score":0.3059999942779541},{"id":"https://openalex.org/C2777182591","wikidata":"https://www.wikidata.org/wiki/Q1878745","display_name":"Lymphomatoid papulosis","level":4,"score":0.30390000343322754},{"id":"https://openalex.org/C2776310896","wikidata":"https://www.wikidata.org/wiki/Q164952","display_name":"Malignant histiocytosis","level":3,"score":0.3028999865055084},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2881999909877777},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.27889999747276306},{"id":"https://openalex.org/C549673821","wikidata":"https://www.wikidata.org/wiki/Q683455","display_name":"Anatomical pathology","level":3,"score":0.272599995136261},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.2651999890804291},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.26489999890327454},{"id":"https://openalex.org/C2778080410","wikidata":"https://www.wikidata.org/wiki/Q5422215","display_name":"Extramedullary hematopoiesis","level":4,"score":0.2635999917984009},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25029999017715454}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1111/cup.70224","doi":"https://doi.org/10.1111/cup.70224","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cup.70224","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cup.70224","source":{"id":"https://openalex.org/S92442678","display_name":"Journal of Cutaneous Pathology","issn_l":"0303-6987","issn":["0303-6987","1600-0560"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cutaneous Pathology","raw_type":"journal-article"},{"id":"pmid:42949567","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42949567","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cutaneous pathology","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.1111/cup.70224","doi":"https://doi.org/10.1111/cup.70224","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cup.70224","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cup.70224","source":{"id":"https://openalex.org/S92442678","display_name":"Journal of Cutaneous Pathology","issn_l":"0303-6987","issn":["0303-6987","1600-0560"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cutaneous Pathology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224128671.pdf","grobid_xml":"https://content.openalex.org/works/W7224128671.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W2295097092","https://openalex.org/W2732399975","https://openalex.org/W2790254562","https://openalex.org/W4205981184","https://openalex.org/W4385827461","https://openalex.org/W4390702604","https://openalex.org/W4408998973","https://openalex.org/W4410025924","https://openalex.org/W4410822787","https://openalex.org/W7127579899"],"related_works":["https://openalex.org/W4410025924","https://openalex.org/W3033284358","https://openalex.org/W2991988544","https://openalex.org/W2765876163","https://openalex.org/W3146815463","https://openalex.org/W4384563656","https://openalex.org/W4413810936","https://openalex.org/W4310962320","https://openalex.org/W2560319132","https://openalex.org/W3153341277"],"abstract_inverted_index":{"Non-Langerhans":[0],"cell":[1],"histiocytoses":[2],"(non-LCH)":[3],"are":[4],"heterogeneous":[5],"histiocytic":[6,76],"neoplasms":[7,77],"driven":[8],"by":[9],"recurrent":[10],"kinase":[11],"pathway":[12],"activation.":[13],"NTRK1":[14],"fusions":[15],"have":[16],"recently":[17],"been":[18],"identified":[19],"as":[20,24],"recurrent,":[21],"actionable":[22],"alterations":[23],"drivers":[25],"of":[26,83],"xanthogranulomatous":[27],"proliferations.":[28],"We":[29],"report":[30],"a":[31],"62-year-old":[32],"man":[33],"with":[34,61],"primary":[35],"myelofibrosis":[36],"(PMF)":[37],"who":[38],"developed":[39],"multifocal,":[40],"symptomatic":[41],"cutaneous":[42,49],"non-LCH":[43],"harboring":[44],"an":[45],"IRF2BP2::NTRK1":[46],"fusion.":[47],"The":[48],"eruption":[50],"was":[51],"refractory":[52],"to":[53,59],"ruxolitinib":[54],"but":[55],"showed":[56],"complete":[57],"response":[58],"larotrectinib,":[60],"successful":[62],"rechallenge":[63],"after":[64],"treatment":[65],"discontinuation.":[66],"This":[67],"case":[68],"illustrates":[69],"targeted":[70],"therapy":[71],"in":[72],"concurrent":[73],"myeloid":[74],"and":[75,78],"expands":[79],"the":[80],"clinical":[81],"spectrum":[82],"NTRK1-rearranged":[84],"histiocytosis.":[85]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-29T00:00:00"}